Geschäftskunden Kundenprogramme
Vor Ort
Merkzettel Warenkorb
Produktbild: Movement Disorders in Psychiatry

Movement Disorders in Psychiatry

Fr. 139.00

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.11.2022

Abbildungen

24 h/t and 13 line illustrations

Herausgeber

Antonio Teixeira + weitere

Verlag

Oxford Academic

Seitenzahl

448

Maße (L/B/H)

25.6/17.7/2.4 cm

Gewicht

798 g

Sprache

Englisch

ISBN

978-0-19-757431-7

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.11.2022

Abbildungen

24 h/t and 13 line illustrations

Herausgeber

Verlag

Oxford Academic

Seitenzahl

448

Maße (L/B/H)

25.6/17.7/2.4 cm

Gewicht

798 g

Sprache

Englisch

ISBN

978-0-19-757431-7

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Movement Disorders in Psychiatry

    • Table of Contents

    • Preface

    • Part I: Movement Disorders Overview

    • Chapter 1: Introduction to the Movement Disorders: Definition and Clinical Phenotypes

    • Erin Furr-Stimming, Jorge Patino Murillas, and William G. Ondo

    • Chapter 2: Pathophysiology of Primary and Secondary Movement Disorders

    • Claudio Da Cunha, William Sánchez-Luna, Fernando Henrique Teixeira Zonzini, Daniel R. Benke, and JosÃ(c) Augusto Pochapski

    • Part II: Movement Disorders Associated with Psychotropics

    • Chapter 3: Dopamine Antagonist-Induced Parkinsonism

    • Abdulmunaim M. Eid and William G. Ondo

    • Chapter 4: Akathisia

    • Satyajit Mohite, Ossama T. Osman, Lokesh Shahani, and Antonio L. Teixeira

    • Chapter 5: Tardive Dyskinesia

    • Vinicius Sousa Pietra Pedroso, João Vinícius Salgado, and Antonio L. Teixeira

    • Chapter 6: Serotonin Syndrome and Neuroleptic Malignant Syndrome

    • Haitham Salem, Brittany Finocchio, and Teresa Pigott

    • Chapter 7: Movement Disorders Associated with SSRIs

    • Jennifer G. Goldman and Carlos Manuel Guerra Galicia

    • Chapter 8: The Under Recognized Movement Disorders Associated with Mood Stabilizers: Lithium, Valproate, Carbamazepine, Lamotrigine

    • Melody Badii and William G. Ondo

    • Chapter 9: Movement Disorders Associated with Stimulants and Other Drugs of Abuse

    • Luiz Paulo Vasconcelos, Jordi Gandini, Antonio L. Teixeira, and Mario Manto

    • Part III: Movement Disorders Seen in Primary Psychiatric Disorders

    • Chapter 10: Neurological Soft Signs in Schizophrenia Spectrum Disorders

    • Johannes Schröder and Christina J. Herold

    • Chapter 11: Stereotypies in Childhood Developmental Disorders and Neurodegenerative Diseases

    • Joohi Jimenez-Shahed

    • Chapter 12: Catatonia and Hypokinetic Movement Disorders

    • Nidaullah Mian, Carla Bejjani, and Raja Mehanna

    • Chapter 13: Functional Movement Disorders

    • Jennifer S. Sharma and Alberto J. Espay

    • Part IV: Diseases with Concurrent Psychiatric and Movement Disorders Symptoms

    • Chapter 14: Tics and Tourette Syndrome

    • Abhishek Lenka and Joseph Jankovic

    • Chapter 15: Huntington's Disease

    • Natalia Pessoa Rocha, Andy Liu, Karen Anderson, and Erin Furr-Stimming

    • Chapter 16: Behavioral Abnormalities in Other Genetic and Non-Genetic Causes of Chorea

    • Ricardo Maciel, DÃ(c)bora Palma Maia, and Francisco Cardoso

    • Chapter 17: Parkinson's Disease and Atypical Parkinsonian Syndromes

    • Julia Ridgeway-Diaz and Laura Marsh

    • Chapter 18: Frontotemporal Dementia: Symptoms, Distinguishing Features, Genetics, Pathology, and Associated Movement Disorders

    • Albert Y. Amran, Avram S. Bukhbinder, and Paul E. Schulz

    • Chapter 19: Restless Legs Syndrome and Psychiatric Issues

    • Emmanuel H. During and John W. Winkelman

    • Chapter 20: Neurometabolic Diseases

    • Nivedita Thakur, Moira Black, Sam Nicholas Russo, and Mary Kay Koenig

    • Chapter 21: Autoimmune and Paraneoplastic Encephalopathies

    • James F. Rini, Bradley T. Peet, and Michael D. Geschwind